Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: First Solar Inc., 3 years.
First Solar Inc.
Director
Option Care Health Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Option Care Health Inc. May 20, 202698.6%
-
First Solar Inc. May 13, 202692.8%
-
Option Care Health Inc. May 16, 202599.1%
-
First Solar Inc. May 14, 202591.5%
-
Option Care Health Inc. May 15, 202498.7%
-
First Solar Inc. May 8, 202492.9%
-
First Solar Inc. May 9, 202394.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 30, 2026 | First Solar Inc. | Grant or award | +223 | — | — |
| May 20, 2026 | Option Care Health Inc. | Grant or award | +8,997 | — | — |
| Mar 31, 2026 | First Solar Inc. | Grant or award | +267 | — | — |
| Dec 31, 2025 | First Solar Inc. | Grant or award | +173 | — | — |
| Sep 30, 2025 | First Solar Inc. | Grant or award | +205 | — | — |
| Sep 9, 2025 | Option Care Health Inc. | Open-market purchase | +3,411 | $29.31 | $99,976 |
| Jun 30, 2025 | First Solar Inc. | Grant or award | +272 | — | — |
| May 14, 2025 | Option Care Health Inc. | Grant or award | +5,034 | — | — |
| Mar 31, 2025 | First Solar Inc. | Grant or award | +356 | — | — |
| Dec 31, 2024 | First Solar Inc. | Grant or award | +256 | — | — |
| Sep 30, 2024 | First Solar Inc. | Grant or award | +181 | — | — |
| Jun 28, 2024 | First Solar Inc. | Grant or award | +200 | — | — |
| May 15, 2024 | Option Care Health Inc. | Grant or award | +5,325 | — | — |
| Apr 1, 2024 | Option Care Health Inc. | Grant or award | +1,731 | — | — |
| Mar 29, 2024 | First Solar Inc. | Grant or award | +267 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.